Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/17/2899990/0/en/Keros-Therapeutics-Announces-Leadership-Updates.html
https://www.globenewswire.com/news-release/2024/06/17/2899467/0/en/Keros-Therapeutics-Presents-Clinical-Data-from-its-Elritercept-KER-050-Program-at-the-29th-Annual-Hybrid-Congress-of-the-European-Hematology-Association.html
https://www.globenewswire.com/news-release/2024/06/04/2892978/0/en/Keros-Therapeutics-to-Host-a-Corporate-Update-Conference-Call-and-Webcast.html
https://www.globenewswire.com/news-release/2024/06/03/2892204/0/en/Keros-Therapeutics-to-Present-at-Goldman-Sachs-45th-Annual-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/28/2889401/0/en/Keros-Therapeutics-Appoints-Jean-Jacques-Bienaim%C3%A9-to-its-Board-of-Directors.html
https://www.globenewswire.com/news-release/2024/05/14/2881560/0/en/Keros-Therapeutics-to-Present-at-the-29th-Annual-Congress-of-the-European-Hematology-Association.html
https://www.globenewswire.com/news-release/2024/05/08/2877768/0/en/Keros-Therapeutics-Reports-Recent-Business-Highlights-and-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/14/2846238/0/en/Keros-Therapeutics-Announces-U-S-FDA-Fast-Track-Designation-for-KER-050-in-Lower-Risk-Myelodysplastic-Syndromes.html
https://www.globenewswire.com//news-release/2024/03/05/2840359/0/en/Keros-Therapeutics-to-Present-at-Leerink-Partners-2024-Global-Biopharma-Conference.html
https://www.globenewswire.com//news-release/2024/02/28/2837390/0/en/Keros-Therapeutics-Reports-Recent-Business-Highlights-and-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html